Epithelioid Haemangioendothelioma Observational Study

Recruiting now

Conditions studied: Clinical Presentation, Natural History, Treatment Outcomes

In brief

The EHE observational study was developed to obtain a high number of datas such as clinical presentation, natural history, and treatment outcomes, cto identificate cytokines and hormones as biomarkers and generate patient-derived preclinical models as a tool to assess the activity of anticancer agents and validate novel therapeutic targets

Key facts

Study ID

NCT06680401

Run by

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

People needed

50

Starts

2021-02-25

Expected to finish

2028-12-01

Last updated by the study team

2026-04-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histological diagnosis of EHE according to 2020 WHO classification, performed on biopsy or surgical specimen
• Signed informed consent
• Adequate patient compliance to treatment or follow up
• No age limit

You may not qualify if…

• Impossibility to ensure adequate compliance

Where it is running

• Fondazione IRCCS IstitutoNazionale dei Tumori — Milan, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.